XR 50 Pill — PINK CAPSULE, 16mm — Quetiapine

No photo available
View full Quetiapine profile
ImprintXR / 50
ColourPINK
ShapeCAPSULE
Size16
StrengthQUETIAPINE FUMARATE 50 mg
Dosage formTablet, Extended Release
ManufacturerAstraZeneca Pharmaceuticals LP
NDC0310-0297
Schedule—
Availability—
IngredientsQUETIAPINE FUMARATE[QUETIAPINE]

What does this imprint mean?

The imprint "XR 50" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Quetiapine

Uses and warnings

BOXED WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA: "Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death." Quetiapine is not approved for this population. SUICIDAL THOUGHTS AND BEHAVIORS: Increased risk documented in children, adolescents, and young adults; close monitoring required. | - Cerebrovascular accidents and stroke risk in elderly dementia patients - Neuroleptic Malignant Syndrome (NMS) - potentially fatal - Metabolic changes: hyperglycemia, dyslipidemia, weight gain - Tardive dyskinesia (involuntary movements) - Orthostatic hypotension and syncope - Seizures in susceptible patients - QT prolongation in overdose scenarios

Quetiapine is "indicated for the treatment of: Schizophrenia... Bipolar I disorder manic episodes... Bipolar disorder, depressive episodes." Used for acute and maintenance treatment across these psychiatric conditions in adults and pediatric patients (ages 10+).

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Quetiapine

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 1a826d85-aac4-42e4-a3e2-a18df915dc33.xml